SCHEMBL25486984

SCHEMBL25486984

COC(=O)c1cc(C)c(-c2cc(C)c(F)cn2)cc1NC(C)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.37
▸ MAPT P10636 2/20 0.36
▸ KDM4E B2RXH2 4/20 0.36
▸ TGFBR1 P36897 1/20 0.36
▸ JAK1 P23458 4/20 0.35
▸ TYK2 P29597 4/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ SMN1; SMN2 Q16637 5/20 0.34
▸ ALDH1A1 P00352 5/20 0.34
▸ LMNA P02545 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ GALR2 O43603 1/20 0.34
▸ MITF O75030 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ XBP1 P17861 1/20 0.34
▸ CCR6 P51684 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ NPC1 O15118 3/20 0.34
▸ RAB9A P51151 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24525182 0.90 DHODH (0.36) DHODHMAPTKDM4ETGFBR1JAK1
SCHEMBL24525000 0.88 CFTR (0.37) DHODHMAPTKDM4ETGFBR1
SCHEMBL29654506 0.88 CFTR (0.37) DHODHMAPTKDM4ETGFBR1
SCHEMBL25486953 0.85 JAK2 (0.46) DHODHMAPTKDM4ETGFBR1TYK2
SCHEMBL24525117 0.81 KDM4E (0.42) DHODHMAPTKDM4ETGFBR1JAK1
SCHEMBL25484858 0.76 ALPL (0.43) MAPTKDM4EDYRK1ASMN1; SMN2ALDH1A1
SCHEMBL25485749 0.75 SLC6A4 (0.52) KDM4ESMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL25485799 0.75 ALDH1A1 (0.42) MAPTKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL25486723 0.73 ABL1 (0.44) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL24525459 0.72 JAK2 (0.43) DHODHMAPTKDM4ETGFBR1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159563-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES ERASCA, INC. 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159563-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES KRAS, NRAS, HRAS DHODH 475/4885MAPT 4642/4885KDM4E 2592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback